Associated Papers
Clinical Benefit of Niraparib to TKI/mTORi-Resistance Metastatic ccRCC With BAP1-Frame Shift Mutation: Case Report and Literature Review.
Lian BJ et al.
Frontiers in Oncology, 2022
35875073 (PubMed )
Supplement: DataSheet_1.xlsx › NGS_somatic_variation_test_resu
Somatic Mutation Profiling in Premalignant Lesions of Vulvar Squamous Cell Carcinoma.
Zięba S et al.
International Journal of Molecular Sciences, 2020
32664330 (PubMed )
Supplement: ijms-21-04880-s001.zip › Table_S1_corrected.xlsx › Arkusz1
Select a paper to view details